{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:36:32Z","timestamp":1768782992672,"version":"3.49.0"},"reference-count":65,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.1851","type":"journal-article","created":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T00:58:06Z","timestamp":1555117086000},"page":"e191851","source":"Crossref","is-referenced-by-count":17,"title":["Assessment of Postdonation Outcomes in US Living Kidney Donors Using Publicly Available Data Sets"],"prefix":"10.1001","volume":"2","author":[{"given":"Jieming","family":"Chen","sequence":"first","affiliation":[{"name":"Bakar Computational Health Sciences Institute, University of California, San Francisco"},{"name":"Department of Pediatrics, University of California, San Francisco"},{"name":"Now with the Department of Bioinformatics and Computational Biology, Genentech, Inc, South San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanchita","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Bakar Computational Health Sciences Institute, University of California, San Francisco"},{"name":"Department of Pediatrics, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Sirota","sequence":"additional","affiliation":[{"name":"Bakar Computational Health Sciences Institute, University of California, San Francisco"},{"name":"Department of Pediatrics, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunisa","family":"Laiudompitak","sequence":"additional","affiliation":[{"name":"Bakar Computational Health Sciences Institute, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Schaefer","sequence":"additional","affiliation":[{"name":"ESAC Inc, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Thomson","sequence":"additional","affiliation":[{"name":"Northrop Grumman Information Systems Health IT, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Wiser","sequence":"additional","affiliation":[{"name":"Northrop Grumman Information Systems Health IT, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minnie M.","family":"Sarwal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, San Francisco"},{"name":"Division of MultiOrgan Transplant, Department of Surgery and Medicine, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul J.","family":"Butte","sequence":"additional","affiliation":[{"name":"Bakar Computational Health Sciences Institute, University of California, San Francisco"},{"name":"Department of Pediatrics, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"issue":"10","key":"zoi190087r2","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ki.2009.20","article-title":"Global trends in the rates of living kidney donation.","volume":"75","author":"Horvat","year":"2009","journal-title":"Kidney Int"},{"issue":"11","key":"zoi190087r3","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.2215\/CJN.01360216","article-title":"Delays in prior living kidney donors receiving priority on the transplant waiting list.","volume":"11","author":"Wainright","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"zoi190087r4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ki.2013.460","article-title":"Long-term risks for kidney donors.","volume":"86","author":"Mj\u00f8en","year":"2014","journal-title":"Kidney Int"},{"issue":"4","key":"zoi190087r5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/ajt.14011","article-title":"Long-term non-end-stage renal disease risks after living kidney donation.","volume":"17","author":"Matas","year":"2017","journal-title":"Am J Transplant"},{"issue":"4","key":"zoi190087r6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1053\/j.ackd.2012.04.010","article-title":"Living donor practices in the United States.","volume":"19","author":"Mandelbrot","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"issue":"12","key":"zoi190087r7","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1111\/ajt.14356","article-title":"The national landscape of living kidney donor follow-up in the United States.","volume":"17","author":"Henderson","year":"2017","journal-title":"Am J Transplant"},{"issue":"8","key":"zoi190087r8","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1111\/ajt.12771","article-title":"Morbidity and mortality of live lung donation: results from the RELIVE study.","volume":"14","author":"Yusen","year":"2014","journal-title":"Am J Transplant"},{"issue":"5","key":"zoi190087r9","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/j.1600-6143.2011.03972.x","article-title":"Complications of living donor hepatic lobectomy: a comprehensive report.","volume":"12","author":"Abecassis","year":"2012","journal-title":"Am J Transplant"},{"key":"zoi190087r10","doi-asserted-by":"publisher","first-page":"180015","DOI":"10.1038\/sdata.2018.15","article-title":"ImmPort, toward repurposing of open access immunological assay data for translational and clinical research.","volume":"5","author":"Bhattacharya","year":"2018","journal-title":"Sci Data"},{"issue":"1","key":"zoi190087r12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/bimj.v57.1","article-title":"Sharing clinical trial data on patient level: opportunities and challenges.","volume":"57","author":"Koenig","year":"2015","journal-title":"Biom J"},{"issue":"2","key":"zoi190087r14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1600-6143.2012.04321.x","article-title":"Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades.","volume":"13","author":"Taler","year":"2013","journal-title":"Am J Transplant"},{"issue":"12","key":"zoi190087r15","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.2215\/CJN.07120714","article-title":"Emotional and financial experiences of kidney donors over the past 50 years: the RELIVE study.","volume":"10","author":"Jacobs","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"zoi190087r16","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1111\/ajt.12906","article-title":"Emotional well-being of living kidney donors: findings from the RELIVE Study.","volume":"14","author":"Jowsey","year":"2014","journal-title":"Am J Transplant"},{"issue":"11","key":"zoi190087r17","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1111\/ajt.12434","article-title":"Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study.","volume":"13","author":"Gross","year":"2013","journal-title":"Am J Transplant"},{"issue":"6","key":"zoi190087r18","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1600-6143.2011.03552.x","article-title":"Living donor age and kidney transplant outcomes.","volume":"11","author":"Noppakun","year":"2011","journal-title":"Am J Transplant"},{"issue":"12","key":"zoi190087r19","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1097\/TP.0000000000000360","article-title":"Satisfaction with life among living kidney donors: a RELIVE study of long-term donor outcomes.","volume":"98","author":"Messersmith","year":"2014","journal-title":"Transplantation"},{"issue":"2","key":"zoi190087r20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/ctr.2011.25.issue-2","article-title":"Assessing elements of informed consent among living donors.","volume":"25","author":"Valapour","year":"2011","journal-title":"Clin Transplant"},{"issue":"8","key":"zoi190087r21","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/(ISSN)1527-6473","article-title":"Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.","volume":"16","author":"Olthoff","year":"2010","journal-title":"Liver Transpl"},{"issue":"7","key":"zoi190087r22","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1111\/ajt.12283","article-title":"Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation.","volume":"13","author":"Cantu","year":"2013","journal-title":"Am J Transplant"},{"issue":"1","key":"zoi190087r23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/ajt.2016.16.issue-1","article-title":"Multicenter analysis of immune biomarkers and heart transplant utcomes: results of the Clinical Trials in Organ Transplantation-05 Study.","volume":"16","author":"Starling","year":"2016","journal-title":"Am J Transplant"},{"issue":"7","key":"zoi190087r24","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1111\/ajt.12286","article-title":"Standardization and cross validation of alloreactive IFN? ELISPOT assays within the Clinical Trials in Organ Transplantation consortium.","volume":"13","author":"Ashoor","year":"2013","journal-title":"Am J Transplant"},{"issue":"1","key":"zoi190087r25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1559-0275-11-7","article-title":"Optimization for peptide sample preparation for urine peptidomics.","volume":"11","author":"Sigdel","year":"2014","journal-title":"Clin Proteomics"},{"issue":"10","key":"zoi190087r26","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1111\/ajt.12426","article-title":"Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.","volume":"13","author":"Hricik","year":"2013","journal-title":"Am J Transplant"},{"issue":"7","key":"zoi190087r27","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/ajt.12284","article-title":"Multicenter evaluation of a standardized protocol for noninvasive gene expression profiling.","volume":"13","author":"Keslar","year":"2013","journal-title":"Am J Transplant"},{"issue":"12","key":"zoi190087r28","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1111\/ajt.v15.12","article-title":"Interferon gamma ELISPOT testing as a risk-stratifying biomarker for kidney transplant injury: results from the CTOT-01 multicenter study.","volume":"15","author":"Hricik","year":"2015","journal-title":"Am J Transplant"},{"issue":"7","key":"zoi190087r29","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/ajt.12287","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.","volume":"13","author":"Reed","year":"2013","journal-title":"Am J Transplant"},{"issue":"2","key":"zoi190087r30","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1681\/ASN.2015010107","article-title":"Urine metabolite profiles predictive of human kidney allograft status.","volume":"27","author":"Suhre","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"zoi190087r31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1215555","article-title":"Urinary-cell mRNA profile and acute cellular rejection in kidney allografts.","volume":"369","author":"Suthanthiran","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi190087r32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1681\/ASN.2005121264","article-title":"Measuring T cell alloreactivity to predict kidney transplant outcomes: are we there yet?","volume":"17","author":"Iacomini","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"zoi190087r33","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1681\/ASN.2006010049","article-title":"Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation.","volume":"17","author":"Harmon","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"zoi190087r34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1046\/j.1399-3046.2003.00148.x","article-title":"Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol.","volume":"8","author":"Schachter","year":"2004","journal-title":"Pediatr Transplant"},{"issue":"8","key":"zoi190087r35","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1002\/eji.v41.8","article-title":"Subsets of human CD4(+) regulatory T cells express the peripheral homing receptor CXCR3.","volume":"41","author":"Hoerning","year":"2011","journal-title":"Eur J Immunol"},{"issue":"10","key":"zoi190087r36","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1111\/j.1600-6143.2012.04253.x","article-title":"A peripheral blood diagnostic test for acute rejection in renal transplantation.","volume":"12","author":"Li","year":"2012","journal-title":"Am J Transplant"},{"issue":"10","key":"zoi190087r37","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1111\/j.1600-6143.2012.04145.x","article-title":"Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up.","volume":"12","author":"Sarwal","year":"2012","journal-title":"Am J Transplant"},{"issue":"10","key":"zoi190087r38","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1111\/j.1600-6143.2012.04144.x","article-title":"Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation.","volume":"12","author":"Naesens","year":"2012","journal-title":"Am J Transplant"},{"issue":"1","key":"zoi190087r39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1600-6143.2009.02767.x","article-title":"A randomized double-blind, placebo controlled trial of steroid withdrawal after pediatric renal transplantation.","volume":"10","author":"Benfield","year":"2010","journal-title":"Am J Transplant"},{"issue":"5","key":"zoi190087r40","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1600-6143.2008.02167.x","article-title":"Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids.","volume":"8","author":"McDonald","year":"2008","journal-title":"Am J Transplant"},{"issue":"1","key":"zoi190087r41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1600-6143.2009.02923.x","article-title":"Steroids in pediatric kidney transplantation: a balancing act in progress.","volume":"10","author":"Magee","year":"2010","journal-title":"Am J Transplant"},{"issue":"1","key":"zoi190087r42","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1681\/ASN.2011040360","article-title":"Immune profile of pediatric renal transplant recipients following alemtuzumab induction.","volume":"23","author":"De Serres","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"zoi190087r43","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1600-6143.2011.03869.x","article-title":"Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients.","volume":"12","author":"Haynes","year":"2012","journal-title":"Am J Transplant"},{"issue":"6","key":"zoi190087r44","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1172\/JCI39933","article-title":"Identification of a B cell signature associated with renal transplant tolerance in humans.","volume":"120","author":"Newell","year":"2010","journal-title":"J Clin Invest"},{"issue":"3","key":"zoi190087r45","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1001\/jama.2011.2014","article-title":"Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants.","volume":"307","author":"Feng","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"zoi190087r46","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/ajt.2009.9.issue-5","article-title":"Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring.","volume":"9","author":"Knechtle","year":"2009","journal-title":"Am J Transplant"},{"issue":"8","key":"zoi190087r47","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1056\/NEJMoa050085","article-title":"Costimulation blockade with belatacept in renal transplantation.","volume":"353","author":"Vincenti","year":"2005","journal-title":"N Engl J Med"},{"issue":"13","key":"zoi190087r48","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/NEJMoa061267","article-title":"International trial of the Edmonton protocol for islet transplantation.","volume":"355","author":"Shapiro","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi190087r49","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/01.TP.0000128332.71657.EA","article-title":"Portal vein thrombosis complicating islet transplantation in a recipient with the Factor V Leiden mutation.","volume":"78","author":"Brennan","year":"2004","journal-title":"Transplantation"},{"issue":"11","key":"zoi190087r50","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"4","key":"zoi190087r51","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1681\/ASN.2017111160","article-title":"The change in living kidney donation in women and men in the United States (2005-2015): a population-based analysis.","volume":"29","author":"Gill","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"zoi190087r52","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1681\/ASN.V781139","article-title":"Gender discrepancies in living related renal transplant donors and recipients.","volume":"7","author":"Bloembergen","year":"1996","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"zoi190087r53","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1023\/A:1016053024671","article-title":"Gender imbalance in living organ donation.","volume":"5","author":"Biller-Andorno","year":"2002","journal-title":"Med Health Care Philos"},{"issue":"4","key":"zoi190087r54","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/archinternmed.2008.605","article-title":"Risk factors for end-stage renal disease: 25-year follow-up.","volume":"169","author":"Hsu","year":"2009","journal-title":"Arch Intern Med"},{"issue":"5","key":"zoi190087r55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0272-6386(03)00372-X","article-title":"Cardiovascular complications in chronic kidney disease.","volume":"41","author":"Sarnak","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"zoi190087r56","first-page":"28","article-title":"Diabetes and end-stage renal disease: a review article on new concepts.","volume":"4","author":"Ghaderian","year":"2015","journal-title":"J Renal Inj Prev"},{"issue":"1","key":"zoi190087r57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward.","volume":"85","author":"Levin","year":"2014","journal-title":"Kidney Int"},{"issue":"8","key":"zoi190087r58","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1111\/ajt.13942","article-title":"White House holds summit on organ transplantation.","volume":"16","author":"Pondrom","year":"2016","journal-title":"Am J Transplant"},{"issue":"12","key":"zoi190087r59","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1111\/ajt.14365","article-title":"The Living Donor Collective: a scientific registry for living donors.","volume":"17","author":"Kasiske","year":"2017","journal-title":"Am J Transplant"},{"issue":"232","key":"zoi190087r60","first-page":"1","article-title":"Mean age of mothers is on the rise: United States, 2000-2014.","author":"Mathews","year":"2016","journal-title":"NCHS Data Brief"},{"issue":"2","key":"zoi190087r61","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1056\/NEJMoa1408932","article-title":"Gestational hypertension and preeclampsia in living kidney donors.","volume":"372","author":"Garg","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi190087r62","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/MNH.0b013e32834bd72b","article-title":"Long-term outcomes of kidney donors.","volume":"20","author":"Morgan","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"zoi190087r63","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13075-015-0778-z","article-title":"Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment.","volume":"17","author":"Nasrallah","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"zoi190087r64","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/HYPERTENSIONAHA.117.10689","article-title":"Influence of gestational age at initiation of antihypertensive therapy: secondary analysis of CHIPS trial data (Control of Hypertension in Pregnancy Study).","volume":"71","author":"Pels","year":"2018","journal-title":"Hypertension"},{"key":"zoi190087r65","article-title":"Novel multi-biomarker assay for non-invasive quantitative monitoring of kidney injury.","author":"Watson","journal-title":"J Exp Med"},{"key":"zoi190087r1","unstructured":"Organ Procurement and Transplant Network National Data. https:\/\/optn.transplant.hrsa.gov\/data\/view-data-reports\/national-data. Accessed September 24, 2016."},{"key":"zoi190087r11","unstructured":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; Health and Human Services. ImmPort. https:\/\/www.immport.org\/home. Accessed February 26, 2019."},{"key":"zoi190087r13","unstructured":"ChenJ, BhattacharyaS, SirotaM, et al. Transplant Trajectory Network. https:\/\/www.immport.org\/resources\/TTN. Accessed March 6, 2019."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/2\/4\/e191851\/17710186\/chen_2019_oi_190087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T22:13:29Z","timestamp":1663280009000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2019.1851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.1851","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]}}}